Cart
sales@molnova.com
N-Demethyl-α-obscurine
CAS No. 34399-44-5
N-Demethyl-α-obscurine( ——— )
Catalog No. M39589 CAS No. 34399-44-5
N-Demethyl-α-obscurine, a lycodine-type Lycopodium alkaloid, is isolated from Lycopodii Herba.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameN-Demethyl-α-obscurine
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Demethyl-α-obscurine, a lycodine-type Lycopodium alkaloid, is isolated from Lycopodii Herba.
-
DescriptionN-Demethyl-alpha-obscurine is a natural product from Lycopodium japonicum.
-
In Vitro———
-
In VivoN-Demethyl-α-obscurine exhibits Cmax (35.53 ng/mL), t1/2 (2.24 h), and AUC0→t (156.91 ng?h/mL) following i.g. administration (L. Herba extract; 4.8 g/kg) in rats.
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number34399-44-5
-
Formula Weight260.37
-
Molecular FormulaC16H24N2O
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ma D, et, al. Pharmacokinetic Studies of Three Alkaloids in Rats After Intragastrical Administration of Lycopodii Herba Extract by LC-MS/MS. Molecules. 2019 May 19;24(10):1930.?
molnova catalog
related products
-
Sugammadex (sodium)
Sugammadex a synthetic derivative of γ-cyclodextrin is a steroid-based neuromuscular blocker reversing agent.
-
Sodium carbonate
Sodium Carbonate, also named as Disodium carbonate, Soda Ash, Carbonic acid disodium salt, is the disodium salt of carbonic acid with alkalinizing property.
-
Ethaselen
Ethaselen (BBSKE) is an orally active and selective thioredoxin reductase 1 (TrxR) inhibitor with anticancer activity that directly inhibits TrxR1 activity and is commonly used in combination with oxaliplatin to inhibit tumor growth.
